December 10, 2015
HealthCap Investor Seminar
Media
December 09, 2015
New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Pulmonx’s Medical Device for Emphysema
December 08, 2015
RSPR Pharma initiates Phase II clinical trial of oral mast cell inhibitor CRD007 in uncontrolled asthma
December 07, 2015
Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing’s Syndrome
December 07, 2015
NORDIC NANOVECTOR PRESENTS PRECLINICAL RESEARCH WITH BETALUTIN® SHOWING POTENTIAL FOR COMBINATION WITH RITUXIMAB IN NON-HODGKIN LYMPHOMA
December 03, 2015
Nexstim Plc Announces Completion of Enrolment of Phase III Clinical Trial in Stroke Therapy
November 30, 2015
HealthCap opens office in Oslo and Ludvik Sandnes appointed as Special Advisor
November 30, 2015
HealthCap opens office in Oslo and Ludvik Sandnes appointed as Special Advisor
November 29, 2015
Q3 2015 General Market Overview
November 26, 2015
Targovax ASA: Interim report third quarter 2015